As it was found that elevated MMP9 levels are positively correlated with a poor prognosis in cancer patients, MMP9 has been suggested as a potential marker candidate for such cancers as breast, colorectal, ovarian, and non-small cell lung cancer [3,4,5,6]. This evidence concerns the gene MMP9 and non-small cell lung carcinoma.